We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Virtus LifeSci Biotech Clinical Trials ETF | AMEX:BBC | AMEX | Exchange Traded Fund |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.0092 | 0.04% | 21.8292 | 21.985 | 21.74 | 21.93 | 3,936 | 21:15:00 |
RNS Number:7566S Ben Bailey PLC 02 December 2003 BEN BAILEY PLC ("the Company") Ben Bailey Plc announces that on 2 December 2003 it issued and allotted 59,870 ordinary shares of 10p each in total to Paul Russell, Chief Executive, pursuant to the exercise of share options. The options were exercised at 38.5p per share. Application will be made for the shares to be admitted to the Official List of the London Stock Exchange. It is expected that dealings in the new shares will commence on Monday 8 December 2003. This information is provided by RNS The company news service from the London Stock Exchange END IOEZLLFBXLBLFBK
1 Year Virtus LifeSci Biotech C... Chart |
1 Month Virtus LifeSci Biotech C... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions